Record Information |
---|
Version | 1.0 |
---|
Created at | 2020-03-18 23:21:46 UTC |
---|
Updated at | 2020-12-07 19:06:55 UTC |
---|
CannabisDB ID | CDB006149 |
---|
Secondary Accession Numbers | Not Available |
---|
Cannabis Compound Identification |
---|
Common Name | Farnesol |
---|
Description | Farnesol belongs to the class of organic compounds known as sesquiterpenoids. These are terpenes with three consecutive (5-carbon) isoprene units. Thus, farnesol is considered to be an isoprenoid lipid molecule. Farnesol pyrophosphate (formed by the reaction of geranyl pyrophosphate reacts with isopentenyl pyrophosphate) is the building block of all acyclic sesquiterpenes. Two sesquiterpenes are paired to form squalene (a 30-carbon terpenoid), which is the precursor for all steroids in plants, animals, and fungi. Farnesol is a very hydrophobic molecule, practically insoluble in water but miscible with oil. Under standard conditions, it is a colorless liquid. Farnesol is present in many essential oils such as citronella, neroli, cyclamen, lemon grass, tuberose, rose, musk, balsam and tolu. It is widely used in perfumery to emphasize the odors of sweet floral perfumes. In addition to being a perfuming agent, farnesol is a natural pesticide for mites and is a pheromone for several other insects. It also exhibits anti-microbial activity. In fact, farnesol is used as a deodorant in cosmetic products because of its anti-bacterial activity (PMID: 18492144 ). Farnesol has also been shown to function as a chemopreventative and anti-tumor agent through the inhibition of phosphatidylcholine biosynthesis, the induction of apoptosis, inhibition of cell cycle progression and actin cytoskeletal disorganization (PMID: 19520495 ). These actions appear to be mediated through farnesol’s regulation/inhibition of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase and CTP:phosphocholine cytidylyltransferase alpha (CCTalpha). HMG-CoA is the rate-limiting enzyme in the mevalonate pathway and CCTalpha is the rate limiting enzyme in phosphatidylcholine biosynthesis (PMID: 19520495 ). Farnesol has also been shown to activate the farnesoid receptor (FXR), a nuclear receptor that forms a functional heterodimer with RXR (Retinoic X receptor). The physiological ligand for FXR remains to be identified; farnesol, may simply mimic the unidentified natural ligand(s). A possible metabolic fate for farnesol is its conversion to farnesoic acid, and then to farnesol-derived dicarboxylic acids (FDDCAs), which would then be excreted in the urine. Farnesol can also be oxidized to a prenyl aldehyde, presumably by mitochondrial or peroxisomal alcohol dehydrogenases (ADH). Liver endoplasmic reticulum and peroxisomal fractions are able to phosphorylate farnesol to farnesyl diphosphate in a cytosine triphosphate (CTP) dependent fashion. (PMID: 9812197 , 8636420 , 9083051 , 9015362 ). |
---|
Structure | |
---|
Synonyms | Value | Source |
---|
(2-cis,6-cis)-3,7,11-Trimethyldodeca-2,6,10-trien-1-ol | ChEBI | (Z,Z)-Farnesol | ChEBI | cis,cis-Farnesol | ChEBI | FARNESOL | ChEBI |
|
---|
Chemical Formula | C15H26O |
---|
Average Molecular Weight | 222.37 |
---|
Monoisotopic Molecular Weight | 222.1984 |
---|
IUPAC Name | (2Z,6Z)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol |
---|
Traditional Name | (Z,Z)-farnesol |
---|
CAS Registry Number | 16106-95-9 |
---|
SMILES | CC(C)=CCC\C(C)=C/CC\C(C)=C/CO |
---|
InChI Identifier | InChI=1S/C15H26O/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-16/h7,9,11,16H,5-6,8,10,12H2,1-4H3/b14-9-,15-11- |
---|
InChI Key | CRDAMVZIKSXKFV-FBXUGWQNSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as sesquiterpenoids. These are terpenes with three consecutive isoprene units. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Prenol lipids |
---|
Sub Class | Sesquiterpenoids |
---|
Direct Parent | Sesquiterpenoids |
---|
Alternative Parents | |
---|
Substituents | - Farsesane sesquiterpenoid
- Sesquiterpenoid
- Fatty alcohol
- Fatty acyl
- Organic oxygen compound
- Hydrocarbon derivative
- Primary alcohol
- Organooxygen compound
- Alcohol
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
|
Role | Industrial application: |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | 283 - 284.00 °C | Wikipedia | Water Solubility | Not Available | Not Available | logP | Not Available | Not Available |
|
---|
Predicted Properties | [] |
---|
Spectra |
---|
EI-MS/GC-MS | Type | Description | Splash Key | View |
---|
GC-MS | Farnesol, non-derivatized, GC-MS Spectrum | splash10-052f-4900000000-1d9e975ae620e9a1e160 | Spectrum | GC-MS | Farnesol, non-derivatized, GC-MS Spectrum | splash10-052f-4900000000-0a9f94e6e357cca02a89 | Spectrum | GC-MS | Farnesol, non-derivatized, GC-MS Spectrum | splash10-052f-3900000000-75812c077a7a432c9c88 | Spectrum | Predicted GC-MS | Farnesol, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-0a4u-9830000000-5e08d59a4cc2e87c9984 | Spectrum |
|
---|
MS/MS | Type | Description | Splash Key | View |
---|
Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0ab9-1590000000-88a1356fe7cab3171954 | 2017-07-25 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0avi-7930000000-81c18181dbd66735216a | 2017-07-25 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0gi0-9400000000-e44ecbea8a96f84abd43 | 2017-07-25 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-00di-0390000000-9beef594142e0da5de92 | 2017-07-26 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-006x-1980000000-3b9708ac6185abaf6d96 | 2017-07-26 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-05bf-4910000000-a8db2089f5647c8532ad | 2017-07-26 | View Spectrum |
|
---|
NMR | Not Available |
---|
Pathways |
---|
Pathways | Not Available |
---|
Protein Targets |
---|
Enzymes | |
---|
Transporters | Not Available |
---|
Metal Bindings | |
---|
Receptors | |
---|
Transcriptional Factors | |
---|
Concentrations Data |
---|
| Not Available |
---|
External Links |
---|
HMDB ID | Not Available |
---|
DrugBank ID | DB02509 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FoodDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | Not Available |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Farnesol |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 1549107 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 42680 |
---|
References |
---|
General References | - Kromidas L, Perrier E, Flanagan J, Rivero R, Bonnet I: Release of antimicrobial actives from microcapsules by the action of axillary bacteria. Int J Cosmet Sci. 2006 Apr;28(2):103-8. doi: 10.1111/j.1467-2494.2006.00283.x. [PubMed:18492144 ]
- Joo JH, Jetten AM: Molecular mechanisms involved in farnesol-induced apoptosis. Cancer Lett. 2010 Jan 28;287(2):123-35. doi: 10.1016/j.canlet.2009.05.015. Epub 2009 Jun 10. [PubMed:19520495 ]
- Edwards PA, Ericsson J: Signaling molecules derived from the cholesterol biosynthetic pathway: mechanisms of action and possible roles in human disease. Curr Opin Lipidol. 1998 Oct;9(5):433-40. doi: 10.1097/00041433-199810000-00007. [PubMed:9812197 ]
- Roullet JB, Xue H, Chapman J, McDougal P, Roullet CM, McCarron DA: Farnesyl analogues inhibit vasoconstriction in animal and human arteries. J Clin Invest. 1996 May 15;97(10):2384-90. doi: 10.1172/JCI118682. [PubMed:8636420 ]
- Bostedor RG, Karkas JD, Arison BH, Bansal VS, Vaidya S, Germershausen JI, Kurtz MM, Bergstrom JD: Farnesol-derived dicarboxylic acids in the urine of animals treated with zaragozic acid A or with farnesol. J Biol Chem. 1997 Apr 4;272(14):9197-203. doi: 10.1074/jbc.272.14.9197. [PubMed:9083051 ]
- Westfall D, Aboushadi N, Shackelford JE, Krisans SK: Metabolism of farnesol: phosphorylation of farnesol by rat liver microsomal and peroxisomal fractions. Biochem Biophys Res Commun. 1997 Jan 23;230(3):562-8. doi: 10.1006/bbrc.1996.6014. [PubMed:9015362 ]
|
---|